Journal of the Society of Cosmetic Scientists of Korea (대한화장품학회지)

Society of Cosmetic Scientists of Korea (대한화장품학회)
권호 표지

The effect of two Terpenoids, Ursolic acid and Oleanolic acid on epidermal permeability barrier and simultaneously on dermal functions

  • Lim Suk Won (R & D Center of Skin Science & Cosmetics, ENPRANI Co., Ltd) ;
  • Jung Sung Won (R & D Center of Skin Science & Cosmetics, ENPRANI Co., Ltd) ;
  • Ahn Sung Ku (Dept. of Dermatology Dermatology, Yonsei Univ. college of Medicine) ;
  • Kim Bora (R & D Center of Skin Science & Cosmetics, ENPRANI Co., Ltd) ;
  • Ryoo Hee Chang (R & D Center of Skin Science & Cosmetics, ENPRANI Co., Ltd) ;
  • Lee Seung Hun (Dept. of Dermatology Dermatology, Yonsei Univ. college of Medicine)
  • Published : 2003.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

Ursolic acid (UA) and Oleanolic acid (ONA), known as urson, micromerol and malol, are pentacyclic triterpenoid compounds which naturally occur in a large number of vegetarian foods, medicinal herbs, and plants. They may occur in their free acid form or as aglycones for triterpenoid saponins, which are comprised of a triterpenoid aglycone, linked to one or more sugar moieties. Therefore UA and ONA are similar in pharmacological activity. Lately scientific research, which led to the identification of UA and ONA, revealed that several pharmacological effects, such as antitumor, hepato-protective, anti-inflammatory, anticarcinogenic, antimicrobial, and anti-hyperlipidemic could be attributed to UA and ONA. Here, we introduced the effect of UA and ONA on acutely barrier disrupted and normal hairless mouse skin. To evaluate the effects of UA and ONA on epidermal permeability barrier recovery, both flanks of 8-12 week-old hairless mice were topically treated with either 0.01-0.1 mg/ml UA or 0.1-1 mg/ml ONA after tape stripping, and TEWL (Transepidermal water loss) was measured . The recovery rate increased in those UA or ONA treated groups (0.1 mg/ml UA and 0.5 mg/ml ONA) at 6 h more than $20\%$ compared to vehicle treated group (p<0.05). Here, we introduced the effects of UA and ONA on acute barrier disruption and normal epidermal permeability barrier function. For verifying the effects of UA and ONA on normal epidermal barrier, hydration and TEWL were measured for 1 and 3 weeks after UA and ONA applications (2mg/ml per day). We also investigated the features of epidermis and dermis using electron microscopy (EM) and light microscopy (LM). Both samples increased hydration compared to vehicle group from f week without TEWL alteration (p<0.005). EM examination using RuO4 and OsO4 fixation revealed that secretion and numbers of lamellar bodies and complete formation of lipid bilayers were most prominent $(ONA{\geq}UA>Vehicle)$. LM finding showed that thickness of stratum corneum (SC) was slightly increased and especially epidermal thickening and flattening was observed (UA>ONA>Veh). We also observed that UA and ONA stimulate epidermal keratinocyte differentiation via $PPAR\;\alpha$. Protein expression of involucrin, loricrin, and filaggrin increased at least 2 and 3 fold in HaCaT cells treated with either $ONA\;(10{\mu}M)$ or UA $(10{\mu}M)$ for 24h respectively. This result suggested that the UA and ONA can improve epidermal permeability barrier function and induce the epidermal keratinocyte differentiation via $PPAR\;{\alpha}$. Using Masson-trichrome and elastic fiber staining, we observed collagen thickening and elastic fiber elongation by UA and ONA treatments. In vitro results of collagen and elastin synthesis and elastase inhibitory activity measurements were also confirmed in vivo findings. These data suggested that the effects of UA and ONA related to not only epidermal permeability barrier functions but also dermal collagen and elastic fiber synthesis. Taken together, UA and ONA can be relevant candidates to improve epidermal and dermal functions and pertinent agents for cosmeseutical applications.

Keywords

References

  1. Schurer NY, Elias PM. The biochemistry and function of stratum corneum lipids. In: Elias P(ed.) Skin Lipids, Advances in Lipid Res San Diego: Academic Press, 1991; 24: 27-56
  2. Downing DT. Lipid and protein structures in the permeability barrier of mammalian epidermis. J Lipid Res 1992; 33: 301-313
  3. Steinert PM. The complexity and redundancy of epithelial barrier function. J Cell Biol 2000; 151: F5-F8 https://doi.org/10.1083/jcb.151.2.F5
  4. Wertz PW, Downing DT. Epidermal lipids. In: Golsmith LA(ed.) Physiology, Biochemistry and Molecular Biology of the skin. New York: Oxford University Press, 1991; 205-236
  5. Lampe MA, Williams ML, Elias PM. Human epidermal lipids: Characterization and modulations during differentiation. J Lipid Res 1983; 24: 131-140
  6. Elias PM and Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991; 24: 1-26
  7. Imokawa G, Akasaki S, Kawamata A et al. Water-retaining function in the stratum corneum and its recovery properties by synthetic pseudoceramide. J Soc Cosmet Chem 1989; 40: 273-285
  8. Huang MT, Ho CT, Wang ZY et al. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 1994; 154(3): 701-8
  9. Tokuda, H., Ohigashi, H., Koshimizu, K et al. Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Letters 1986; 33:279-285 https://doi.org/10.1016/0304-3835(86)90067-4
  10. Ohigashi H, Takamura H, Koshimizu K et al. Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation; ursolic acid and oleanolic acid from an anti-inflammatory Chinese medicinal plant, Glechoma hederaceae L. Cancer Lett 1986; 30(2): 143-51 https://doi.org/10.1016/0304-3835(86)90082-0
  11. Hollosy F, Meszaros G, Bokonyi G et al. cytotoxic and protein tyrosine kinase inhibitory activity of ursolic acid in A431 human tumor cells. Anticancer Res 2000; 20: 4563-4570
  12. Choi CY, You HJ, Jeong HG. Nitric oxide and tumor necrosis factor-a production by oleanolic acid via $NF-_KB$ activation in macrophages. Biochem Biophys Res Commun 2001; 288: 49-55 https://doi.org/10.1006/bbrc.2001.5727
  13. Subbaramaiah K, Michaluart P, Sporn MB et al. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res 2000; 60: 2399-2404
  14. Mahto SB, Sarkar SK, Poddar G. phytochemistry 1988; 7: 3037-3067
  15. Liu J Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 1995; 49: 57-68
  16. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995; 83:841-850 https://doi.org/10.1016/0092-8674(95)90200-7
  17. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996; 37: 907-925
  18. Kersten S, Desvergne B, Wahli W. Roles of PPAR in health and disease. Nature 2000; 405:421-424 https://doi.org/10.1038/35013000
  19. River M, Safonova I, Lebrun P et al. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of keratinocytes. J Invest Dermatol 1998; 111: 1116-1121 https://doi.org/10.1046/j.1523-1747.1998.00439.x
  20. River M, Casiel I, Safonova I et al. Peroxisome proliferator activated receptor- enhances lipid metabolism in a skin equivalent model. J Invest Dermatol 2000; 114: 681-687 https://doi.org/10.1046/j.1523-1747.2000.00939.x
  21. Hanley K, Jiang Y, He SS et al. Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor peroxisome proliferator-activated receptor-a. J Invest Dermatol 1998; 110: 368-375 https://doi.org/10.1046/j.1523-1747.1998.00139.x
  22. Hanley K, Jiang Y, Crumrine D et al. Activators of the nuclear hormone receptors PPAR $\alpha$ and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest 1997; 100: 705-712 https://doi.org/10.1172/JCI119583
  23. Hanley K, Komuves LG, Bass NB et al. Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators. J Invest Dermatol 1999; 113: 788-795 https://doi.org/10.1046/j.1523-1747.1999.00743.x
  24. Komuves LG, Hanley K, Lefebver AM et al. Stimulation of PPAR a promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol 2000; 115: 353-360 https://doi.org/10.1046/j.1523-1747.2000.00073.x
  25. Komuves LG, Hanley K, Man MQ et al. Keratinocytes differentiation in hyperproliferative epidermis: topical application of PPAR a activators restores tissue homeostasis. J Invest Dermatol 2000; 115: 361-367 https://doi.org/10.1046/j.1523-1747.2000.00076.x
  26. Pinnagoda J, Tupker RA, Agner T ea al. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis. 1990; 22: 164-178 https://doi.org/10.1111/j.1600-0536.1990.tb01553.x
  27. Grubauer G, Feingold KR, Elias PM. Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res 1989; 30: 323-333
  28. Choi EH, Ahn SK, Lee SH. The changes of stratum corneum interstices and calcium distribution of follicular epithelium of experimentally induced comedones (EIC) by oleic acid. Exp Dermatol 1997; 6: 29-35 https://doi.org/10.1111/j.1600-0625.1997.tb00142.x
  29. Ahn SK, Hwang SM, Jiang SJ et al. The changes of epidermal calcium gradient and transitional cells after prolonged occlusion followinq tape stripping in murine epidermis. J Invest Dermatol 1999; 113: 189-195 https://doi.org/10.1046/j.1523-1747.1999.00650.x
  30. Keller H, Drayer C, Medin J et al. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci 1993; 90: 2160-2164 https://doi.org/10.1073/pnas.90.6.2160
  31. Yu K, Bayona W, Kallen CB et al. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 1995; 270: 23975-23983 https://doi.org/10.1074/jbc.270.41.23975
  32. Tang HQ, Hu J, Yang L et al. Terpenoids and flavonoids from Artemisia species. Planta Med 2000; 66: 391-393 https://doi.org/10.1055/s-2000-8538
  33. Jeong TS, Hwang EI, Lee HB et al. Chitin synthase II inhibitory activity of ursolic acid, isolated from crataegus pinnatifida. Planta Med 1999; 65: 261-263 https://doi.org/10.1055/s-2006-960474
  34. Marquina S, Maldonado N, Garduno-Ramirez ML et al. Bioactive oleanolic acid saponins and other constituents from the roots of Viguiera decurrens. Phytochemistry 2001; 56: 93-97 https://doi.org/10.1016/S0031-9422(00)00283-1
  35. Kashiwada Y, Nagao T, Hashimoto A et al. Anti-AIDS agents.38. Anti-HIV activity of 3-O-acyl ursolic acid derivatives. J Nat Prod 2000; 63: 1619-1622 https://doi.org/10.1021/np990633v
  36. Ma C, Nakamura N, Hattori M et al. Inhibitory effects on HIV-1 protease of constituents from the wood of Xanthoceras sorbifolia. J Nat Prod 2000; 63: 238-242 https://doi.org/10.1021/np9902441
  37. Alvarez ME, Maria AO, Saad JR. Diuretic activity of Fabiana patagonica in rats. Phytother Res 2002; 16: 71-73
  38. Assefa H, Nimrod A, Walker L et al. Enantioselective synthesis and complement inhibitory assay of A/B-ring partial analogues of oleanolic acid. Bioorg Med Chem Lett 2001; 11: 1619-1623 https://doi.org/10.1016/S0960-894X(01)00210-4
  39. Yim TK, Wu WK, Pak WF et al. Hepatoprotective action of an oleanolic acid-enriched extract of Ligustrum lucidum fruits is mediated through an enhancement on hepatic glutathione regeneration capacity in mice. Phytother Res 2001; 15: 589-592 https://doi.org/10.1002/ptr.878
  40. Saraswat B, Visen PK, Agarwal DP. Ursolic acid isolated from Eucalyptus tereticornis protects against ethanol toxicity in isolated rat hepatocytes. Phytother Res 2000; 14: 163-166 https://doi.org/10.1002/(SICI)1099-1573(200005)14:3<163::AID-PTR588>3.0.CO;2-D
  41. Latha PG, Panikkar KR. Modulatory effects of ixora coccinea flower on cyclophosphamide-induced toxicity in mice. Phytother Res 1999; 13: 517-520 https://doi.org/10.1002/(SICI)1099-1573(199909)13:6<517::AID-PTR524>3.0.CO;2-Y
  42. Jeong HG. Inhibition of cytochrome P450 2E1 expression by oleanolic acid hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol Lett 1999; 105: 215-222 https://doi.org/10.1016/S0378-4274(99)00004-1
  43. Ismaili H, Tortora S, Sosa S et al. Topical anti-inflammatory activity of Thymus willdenowii. J Pharm Pharmacol 2001; 53: 1645-1652 https://doi.org/10.1211/0022357011778250
  44. Giner-Larza EM, Manez S, Recio MC et al. Oleanolic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity. Eur J Pharmacol 2001; 428: 137-143 https://doi.org/10.1016/S0014-2999(01)01290-0
  45. Ryu SY, Oak MH, Yoon SK et al. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med 2000; 66: 358-360 https://doi.org/10.1055/s-2000-8531
  46. Baricevic D, Sosa S, Della Loggia R et al. Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. J Ethnopharmacol 2001; 75: 125-132 https://doi.org/10.1016/S0378-8741(00)00396-2
  47. Li J, Xu LZ, Zhu WP et al. Effects of ursolic acid and oleanolic acid on Jurkat lymphoma cell line in vitro. Zhongguo Aizheng Zazhi 1999; 9: 395-397
  48. Hollosy F, Idei M, Csorba G et al. Activation of caspase-3 protease during the process of ursolic acid and its derivative-induced apoptosis. Anticancer Res 2001; 21: 3485-3491
  49. Rios MY, Gonzalez-Morales A, Villarreal ML. Sterols, triterpenes and biflavonoids of Viburnum jucundum and cytotoxic activity of ursolic acid. Planta Med 2001; 67: 683-684 https://doi.org/10.1055/s-2001-17357
  50. Martin-Cordero C, Reyes M, Ayuso MJ et al. Cytotoxic triterpenoids from Erica andevalensis. Z Naturforsch [C] 2001; 56: 45-48
  51. Lauthier F, Taillet L, Trouillas P et al. Ursolic acid triggers calcium-dependent apoptosis in human Daudi cells. Anticancer Drugs 2000; 11: 737-745
  52. Ko HH, Yen MH, Wu RR et al. Cytotoxic isoprenylated flavans of Broussonetia kazinoki. J Nat Prod 1999; 62: 164-166 https://doi.org/10.1021/np980281c
  53. Cha HJ, Park MT, Chung HY et al. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells. Oncogene 1998; 16: 771-778 https://doi.org/10.1038/sj.onc.1201587
  54. Muto Y, Ninomiya M, Fujiki H. Present status research on cancer chemoprevention in Japan. Japanese J. of Clinical Oncology 1990; 20: 219-224
  55. Landmann L. Epidermal permeability barrier: transformation of lamella-granule disks into intercellular sheets by membrane-fusion process, a freeze-fracture study. J Invest Dermatol 1986; 87: 202-209 https://doi.org/10.1111/1523-1747.ep12695343
  56. Matsuura H, Adachi H, Smart RC et al. Correlation between expression of peroxisome proliferator-activated receptor $\beta$ and tracheobronchial epithelial cells. Mol Cell Endocrinol 1999; 147: 85-92 https://doi.org/10.1016/S0303-7207(98)00214-7
  57. Kliwer SA, Umesono K, Noonan DJ et al. Convergence of 9-cis retinoid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature 1992; 358: 771-774 https://doi.org/10.1038/358771a0
  58. Mukherjee R, Strasser J, Jow L et al. RXR agonists activate PPAR -inducible genes, lower triglycerides, and raise HDL levels in vivo. Arterioscler Thromb Vasc Biol 1998; 18: 272-276
  59. Fuchs E. Epidermal differentiation: the bare essentials. J Cell Biol 1990; 111: 2807-2814 https://doi.org/10.1083/jcb.111.6.2807
  60. Wang Y, Porter WW, Suh N et al. A synthetic triterpenoid, 2-cyano-3, 12-dioxooleana-1,9dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor $\gamma$. Mol Endocrinol 2000; 14: 1550-1556 https://doi.org/10.1210/me.14.10.1550
  61. Xu HE, Lambert MH, Montana VG et al. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 1997; 94: 4318-4323 https://doi.org/10.1073/pnas.94.9.4318
  62. Xu HE, Lambert MH, Montana VG et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 1999; 3: 397-403 https://doi.org/10.1016/S1097-2765(00)80467-0
  63. Gottlicher M, Widmark E, Li Q et al. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 1992 15; 89: 4653-4657 https://doi.org/10.1073/pnas.89.10.4653
  64. Gottlicher M, Demoz A, Svensson D et al. Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor. Biochem Pharmacol 1993; 46: 2177-2184 https://doi.org/10.1016/0006-2952(93)90607-X
  65. Kliewer SA, Sundseth SS. Jones SA et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors a and Proc Natl Acad Sci USA 1997; 94: 4318-4323
  66. Rogers J, Harding C, Mayo A et al. Stratum corneum lipids: the effects of ageing and the seasons. Arch Dermatol Res 1996; 288: 765-770 https://doi.org/10.1007/BF02505294
  67. Both D, Goodzova K, Yarosh DB et al. Liposome-encapsulated ursolic acid increased ceramides and collagen in human skin cells. Arch Dermatol Res 2002; 293: 569-575
  68. Griffiths CEM, Voorhees JJ. Topical retinoic acid for photoaging: clinical response and underlying mechanisms. Skin Pharmacol 1993; 6: 70-77 https://doi.org/10.1159/000211166
  69. Gendimenico GJ, Mezick JA. Pharmacological effects of retinoids on skin cells. Skin Pharmacol 1993; 6: 24-34 https://doi.org/10.1159/000211161
  70. Ponec M, Weerheim A, Kempenaar J et al. Retinoids and lipid changes in keratinocytes. Methods Enzymol 190:30-41
  71. Nishimori Y, Tsuruoka H, Matsumoto K et al. A new approach for the improvement of photoaged skin through collagen fiber bundle reconstruction mechanism. In: Proceedings of the 20th International Federation of Societies of Cosmetic Chemists Congress, Section O009, pp 1-21
  72. Yarosh DB, Both D, Brown D. Liposomal ursolic acid (merotaine) increases ceramides and collagen in human skin. Horm Res 2000; 54: 318-321 https://doi.org/10.1159/000053280
  73. James AEK, Timothy DW and Gorden L. Inhibition of human leucocyte and porcine pancreatic elastase by homologues of bovine pancreatic truosin inhibitors. Biochemistry 1996; 35: 9090-9096 https://doi.org/10.1021/bi953013b
  74. Uitto J, Bernstein EF. Molecular mechanisms of cutaneous aging: connective tissue alterations in the dermis. J Invest Dermatol 1998; 3: 41-44
  75. Tsukahara K. Moriwaki S, Fujimura T et al. Inhibitory effect of an extract of Sanguisorba officinalis L. on ultraviolet-B-Induced photodamage of rat skin. Biol Pharm Bull 2001; 24:998-1003 https://doi.org/10.1248/bpb.24.998
  76. Bolognia JL, Braverman IM, Rousseau ME et al. Skin changes in menopause. Maturitas 1989; 11:295-304 https://doi.org/10.1016/0378-5122(89)90026-1